biohazardous because no infectious virus particles are used. Their validity in screening for antiHIVsubstances which inhibit syncytium formation was confirmed using various knownHIV entry inhibitors.
Progress of combination chemotherapy with HIV-1 reverse transcriptase and protease inhibitors has achieved long sustained suppression of viral replication in HIV-1-infected individuals1}. However, considering a low compliance of long-term combination chemotherapy and emergence of the mutant viruses resistant to these drugs, it is still necessary to discover novel anti-HIV-1 agents with different mechanismof action2). The envelope glycoprotein gpl20/gp41 of HIV-1 binds the cellular receptors and mediates the fusion between the viral and cellular membranes. This process is an attractive target for the drugs to prevent the HIV-1 infection of its target cells. We have tried screening for new antibiotics active against gpl20-CD4 binding from soil microorganisms, and found isochromophilones I and II from Penicillium multicolor3^and chloropeptin from Streptomyces sp.6~8) by gp l20-sCD4 binding assay. The fusogenic properties of the HIVenvelope can also lead to fusion between the env-expressing cell lines and other CD4+ cells9). When these cell lines are co-incubated, the large syncytia are formed. Recently, it is clarified that the cell-tropism of HIV-1 depends on species of chemokine receptors such as CXCR4 or CCR5, and that these receptors function as a co-receptor for the virus binding to the cell surfacelo'n). So, we developed two syncytium formation systems using the recombinant cell lines. The one is the T-cell line (T-) tropic system using HeLa/CD4/Lac-Z and HeLa/T-env/Tat. The other is the macrophage (M-) tropic system using HOS/CD4/CCR5/Lac-Z and HeLa/M-env/Tat.
Then, we tried to validate the systems using the known HIV-1 entry inhibitors and to screen anti-HIV substances. The present paper deals with the establishment and validation of the screening systems.
Materials and Methods
C ompounds
Benanomicin A12) and cyanovirin-N13) were generous gifts from Drs. T. Takeuchi (Microbial Chemistry Institute, Tokyo, Japan) and M. R. Boyd (National Cancer Institute, MD), respectively. T13414) and T14015) were generous gifts from Dr. H. Nakashima (Kagoshima Univ., Kagoshima, Japan was purchased from Nisshinbo (Tokyo, Japan). The plasmid pSF162 which contains a 3.2 kilobase (Kb) EcoRl-Xhol fragment encoding the C-terminal 35 amino-acid residues of vpr, tat, rev, vpu and env gene products and the Nterminal 36 or 38 amino-acid residues of nefgene product was a generous gift from Dr. T. Shioda18'19) (Osaka Univ.
Research Institute for Microbial Diseases, Osaka, Japan). HeLa cells were transfected with PNCRVE-SF162 and cultured in the medium containing 1 mg ofG-418 per ml in a 100-mmdiameter culture dish for 2 weeks. The colonies were cloned by limiting dilution and expanded in 25cm2 culture flasks (HeLa/M-env).
The plasmids PHIV-LacZ and pMAM2-BSD were cotransfected into HeLa/CD422) and HOS/CD4/CCR5 cells. The PCMV-Tatand pMAM2-BSD were co-transfected into HeLa/T-env (HeLal35)20) and HeLa/M-env cells. The transfected cells werecultured in the mediumcontaining 2^g ofblastcidin S per ml for 2 weeks. The colonies were cloned by limiting dilution and expanded in 25 cm2 culture flasks to obtain HeLa/CD4/LacZ, HOS/CD4/CCR5/LacZ, HeLa/T-env/Tat and HeLa/M-env/Tat.
Western Blot Analysis
To detect env protein expressed in HeLa/M-envcells, 5X 105 cells were cultured in a 60-mmdiameter culture dish for 18 hours. The cells were washed with phosphate buffered saline (PBS), collected by a policeman and centrifuged at 800Xg for 5 minutes at 4°C. The cells were resuspended in lysis buffer (1% Nonidet P-40, 0.5% deoxycholic acid, 150mM NaCl, 50mMTris-HCl, pH 8.0) and stood on a ice bath for 30 minutes. The cell lysate was centrifuged at 9,000X0 for 5 minutes at 4°C and the supernatant fluid was subjected to SDS-polyacrylamide gel electrophoresis. Proteins in the gel were electrophoretically transferred to PVDFmembrane (Millipore, MA)using a semi-dry blotting apparatus (Biocraft, Tokyo, Japan 
Results and Discussion

Construction of Cell Lines for Syncytium Formation
It is known that the envelope glycoprotein gpl20/gp41 of HIV-1 binds the cellular receptors and mediates the fusion between the viral and cellular membranes, and that such fusion can also occur between the env-expressing cell lines 
Validation of the Assay Systems Using KnownHIV Entry Inhibitors
To confirm whether these assay systems reflect the tropism of HIV env protein, the inhibitory effects of the known HIVentry inhibitors were investigated using the systems. Noneof the test compoundsemployed were found to be cytotoxic at the concentrations used in the assay (data not shown). Figure 5 shows the syncytium formation in the presence of the inhibitors. Chloropeptin I6), which was discovered as a gpl20-CD4 binding inhibitor from Streptomyces sp. inhibited both T-tropic and M-tropic syncytium formation, with the 50% inhibitory concentration (IC50) values of 2.0 and 2.4^um, respectively.
Cyanovirin-N13), which was isolated from the cyanobacterium Nostoc ellipsosporum and found to interact with HIV env, also inhibited both systems with IC50 values of40 and 50 nM, respectively. Benanomicin Au\ which is a mannose-binding antibiotic having antifungal and anti-HIV activities in the presence of calcium ions, also inhibited both syncytium formation with IC50 values of 10 and 12 //m, respectively. T13414) and T14015), which are known to bind CXCR4receptor of the host cells and to exhibit a potent anti-HIV activity, inhibited T-tropic system with IC50 values of 0.5 and 0.3nM, respectively, but not M-tropic system even at 1.0^M. On the other hand, TAK-77916), a small molecular non-peptide antagonist of CCR5receptor, inhibited M-tropic system alone with IC50 values of 2 nM.
These data indicate that the above systems are useful in measuring selectively the syncytium formation mediated by T-or M-tropic env protein and the chemokine receptor CXCR4or CCR5, respectively.
Thus, it was confirmed that the syncytium formation systems are useful in screening for anti-HIV substances having specific inhibitory activities against HIVentry to cells, and that the inhibitory activity against T-or M-tropism can be differentiated using the systems.
Screening of Syncytium Formation Inhibitors from Microorganisms
Using the above T-cell tropic system, we have screened syncytium formation inhibitors from microorganisms isolated in the Kitasato Institute and our laboratory. Over 8000 microogsnisms including actinomycetes and fungi were tested and we discovered a novel anti-HIV protein (actinohivin) inhibiting syncytium formation from the culture supernatant of the actinomycete strain K97-0003. The compoundhas been revealed to be a protein consisting of 1 14 amino acid residues and to inhibit T-and M-tropic syncytium formation with IC50 values of 60 and 700nM, respectively, and the cytopathicity of HIVIIIB in MT-4 cells with IC50 values of 230 nM26). Isolation, characterization, biological activities, and molecular cloning of actinohivin have been published in the separate papers26'27).
Several assay systems for syncytium formation have been reported9'28~30).
They depend on the use of infectious virus particles and/or the transfection with plasmids or bacteriophages. The assay system reported here does not 
